Barclays analyst Luke Sergott raised the firm’s price target on Thermo Fisher to $625 from $590 and keeps an Overweight rating on the shares post the Q2 results. The company’s “big guidance cut and feels kitchen-sinked,” the analyst tells investors in a research note. The firm says this is most likely the last and only cut to the year.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TMO:
- Thermo Fisher Scientific Earnings Report: Did it Beat Expectations?
- Thermo Fisher says macro environment has become more challenged
- Thermo Fisher (NYSE:TMO) Cools Down on Big Q2 Miss
- Thermo Fisher cuts FY23 adjusted EPS view to $22.28-$22.72 from $23.70
- Thermo Fisher reports Q2 adjusted EPS $5.15, consensus $5.42